Comorbid Infections in Spondyloarthritis: the Current State of the Problem
Comorbid infections (CI) in immuno-inflammatory rheumatic diseases (IIRDs) are associated with significant morbidity and mortality and, in addition, involve significant costs in the health care system due to the need for additional treatment and hospitalization. The development of CI requires the te...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2025-04-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/1215 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850063529469542400 |
|---|---|
| author | M. M. Baranova N. V. Muravyeva B. S. Belov |
| author_facet | M. M. Baranova N. V. Muravyeva B. S. Belov |
| author_sort | M. M. Baranova |
| collection | DOAJ |
| description | Comorbid infections (CI) in immuno-inflammatory rheumatic diseases (IIRDs) are associated with significant morbidity and mortality and, in addition, involve significant costs in the health care system due to the need for additional treatment and hospitalization. The development of CI requires the temporary cancellation of ongoing immunosuppressive therapy, which can lead to an exacerbation of IIRD. High activity of rheumatic disease and treatment with immunosuppressive drugs may increase the risk of CI. Of particular interest is the study of the frequency, structure and risk factors in patients with spondyloarthritis (SpA) — ankylosing spondylitis (AS) and psoriatic arthritis (PsA), especially in the aspect of the increasing use of biologics or targeted (b/tsDMARD) modifying disease agents and contradictory literature data. |
| format | Article |
| id | doaj-art-8720db6b516b483eaefbc73df14e4dfd |
| institution | DOAJ |
| issn | 0235-2990 |
| language | Russian |
| publishDate | 2025-04-01 |
| publisher | LLC "Publishing House OKI" |
| record_format | Article |
| series | Антибиотики и Химиотерапия |
| spelling | doaj-art-8720db6b516b483eaefbc73df14e4dfd2025-08-20T02:49:34ZrusLLC "Publishing House OKI"Антибиотики и Химиотерапия0235-29902025-04-016911-1212713510.37489/0235-2990-2024-69-11-12-127-1351085Comorbid Infections in Spondyloarthritis: the Current State of the ProblemM. M. Baranova0N. V. Muravyeva1B. S. Belov2V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyComorbid infections (CI) in immuno-inflammatory rheumatic diseases (IIRDs) are associated with significant morbidity and mortality and, in addition, involve significant costs in the health care system due to the need for additional treatment and hospitalization. The development of CI requires the temporary cancellation of ongoing immunosuppressive therapy, which can lead to an exacerbation of IIRD. High activity of rheumatic disease and treatment with immunosuppressive drugs may increase the risk of CI. Of particular interest is the study of the frequency, structure and risk factors in patients with spondyloarthritis (SpA) — ankylosing spondylitis (AS) and psoriatic arthritis (PsA), especially in the aspect of the increasing use of biologics or targeted (b/tsDMARD) modifying disease agents and contradictory literature data.https://www.antibiotics-chemotherapy.ru/jour/article/view/1215comorbid infectionsspondyloarthritisankylosing spondylitispsoriatic arthritisbiologics modifying disease agents |
| spellingShingle | M. M. Baranova N. V. Muravyeva B. S. Belov Comorbid Infections in Spondyloarthritis: the Current State of the Problem Антибиотики и Химиотерапия comorbid infections spondyloarthritis ankylosing spondylitis psoriatic arthritis biologics modifying disease agents |
| title | Comorbid Infections in Spondyloarthritis: the Current State of the Problem |
| title_full | Comorbid Infections in Spondyloarthritis: the Current State of the Problem |
| title_fullStr | Comorbid Infections in Spondyloarthritis: the Current State of the Problem |
| title_full_unstemmed | Comorbid Infections in Spondyloarthritis: the Current State of the Problem |
| title_short | Comorbid Infections in Spondyloarthritis: the Current State of the Problem |
| title_sort | comorbid infections in spondyloarthritis the current state of the problem |
| topic | comorbid infections spondyloarthritis ankylosing spondylitis psoriatic arthritis biologics modifying disease agents |
| url | https://www.antibiotics-chemotherapy.ru/jour/article/view/1215 |
| work_keys_str_mv | AT mmbaranova comorbidinfectionsinspondyloarthritisthecurrentstateoftheproblem AT nvmuravyeva comorbidinfectionsinspondyloarthritisthecurrentstateoftheproblem AT bsbelov comorbidinfectionsinspondyloarthritisthecurrentstateoftheproblem |